Literature DB >> 2118187

Immunogenicity and cross-reactivity of the 70-Kda iron-regulated protein of Neisseria meningitidis in man and animals.

D A Ala'Aldeen1, R A Wall, S P Borriello.   

Abstract

The immune response to different serogroups and serotypes of N. meningitidis has been examined in acute and convalescent sera from patients with meningococcal diseases. The focus of the study was the c. 70-Kda iron-regulated outer-membrane protein (FeRP-70). FeRP-70 was demonstrated on all strains of different serogroups and serotypes examined by sodium dodecylsulphate-polyacrylamide gel electrophoresis or Western blots of outer-membrane proteins (OMPs). Immunoblotting experiments demonstrated the presence of considerable amounts of anti-FeRP-70 IgG antibodies in the acute and convalescent sera of six patients; the antibodies reacted with homologous and heterologous strains. However, sera from two patients who died of severe meningococcal septicaemia had no antibodies against FeRP-70 or any other OMPs demonstrable by immunoblotting. Absorbed rabbit hyperimmune sera reacted with FeRP-70 of their homologous strains, but, unlike human sera, with only a few of the heterologous strains. We believe that FeRP-70 is strongly immunogenic in vivo, cross-reactive amongst different strains, and that man and animals differ considerably in their response to similar meningococcal antigens. The functional attribution of human antibody response against this protein requires further exploration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118187     DOI: 10.1099/00222615-32-4-275

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  The iron-repressed, AraC-like regulator MpeR activates expression of fetA in Neisseria gonorrhoeae.

Authors:  Aimee Hollander; Alexandra Dubon Mercante; William M Shafer; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

2.  Role of Neisseria meningitidis luxS in cell-to-cell signaling and bacteremic infection.

Authors:  Klaus Winzer; Yao-hui Sun; Andrew Green; Marie Delory; David Blackley; Kim R Hardie; Thomas J Baldwin; Christoph M Tang
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Transferrin-binding protein B isolated from Neisseria meningitidis discriminates between apo and diferric human transferrin.

Authors:  I C Boulton; A R Gorringe; N Allison; A Robinson; B Gorinsky; C L Joannou; R W Evans
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

4.  Localization of the meningococcal receptors for human transferrin.

Authors:  D A Ala'Aldeen; N B Powell; R A Wall; S P Borriello
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

5.  Iron starvation of Bordetella avium stimulates expression of five outer membrane proteins and regulates a gene involved in acquiring iron from serum.

Authors:  T D Connell; A Dickenson; A J Martone; K T Militello; M J Filiatraut; M L Hayman; J Pitula
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

6.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design.

Authors:  D A Ala'Aldeen; P Stevenson; E Griffiths; A R Gorringe; L I Irons; A Robinson; S Hyde; S P Borriello
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 8.  Iron and bacterial virulence--a brief overview.

Authors:  E Griffiths
Journal:  Biol Met       Date:  1991

9.  FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.

Authors:  Holly Sanders; Gunnstein Norheim; Hannah Chan; Christina Dold; Caroline Vipond; Jeremy P Derrick; Andrew J Pollard; Martin C J Maiden; Ian M Feavers
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.